Stephen A. Hurly serves as Executive at Eleven Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Stephen A. Hurly has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 13, 2025 involved selling 5,000 shares valued at $0.
Stephen A. Hurly currently holds 398,031 shares of Eleven Biotherapeutics, Inc. (EBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen A. Hurly has been a net neutral trader of EBIO stock. They have purchased $0 and sold $0 worth of shares.
Stephen A. Hurly's most recent insider trade was on Nov 13, 2025, when they sold 5,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |